Clinical trial
Local Phase 4 Pan-European SMART Study
NCT00463866 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Local Phase 4 Pan-European SMART Study
- Lead sponsor
- AstraZeneca
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2007
- Completion date
- December 31, 2008
- Enrollment
- 8,424 (actual)
- Sites
- 817
Conditions
As the registry lists them; a condition with its own page is linked.